Barbara W. Unger
President, Unger Consulting
Areas examined in this report:
- In-depth analysis of FDA Warning Letters issued in FY2020 and FY2021
- FDA enforcement trends as indicated by this analysis
- How these trends compare to enforcement trends since FY2013